Close Menu

NEW YORK (GenomeWeb) WIRB-Copernicus Group (WCG) today said that its Clinical Services Division has entered a strategic partnership with InformedDNA, under which the companies will create a new "Center for Genetics and Precision Medicine in Clinical Trials," offering support services to biopharmaceutical companies, contract research organizations, and academic institutions in the design and conduct of precision medicine clinical trials.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.